Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 15, Issue 18
|
pp. 9633–9660
A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients
Back to article
Figure 2
(2 of 13)
−
100%
+
Figure 2.
The expression levels of Gefitinib target genes in LUAD tissues.
(
A
) High expression; (
B
) Low expression. Abbreviations: LUAD: Lung adenocarcinoma; T: LUAD tissues; N: normal tissues.